SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nuveen New York Municipal Value Fund (NNY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 36/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NNY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio21.72
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.17
Book Value / Share$0.00
Revenue / Share$0.40
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.66 |
$6.61M |
$-10.05M |
-152% |
| 2017 |
$0.30 |
$6.48M |
$4.53M |
69.8% |
| 2018 |
$0.42 |
$6.94M |
$6.45M |
92.9% |
| 2019 |
$0.93 |
$14.37M |
$14.23M |
99% |
| 2020 |
$-0.02 |
$-124.06K |
$-296.66K |
- |
| 2021 |
$-0.01 |
$206.67K |
$-102.05K |
-49.4% |
| 2022 |
$-0.67 |
$-12.44M |
$-12.58M |
- |
| 2023 |
$0.51 |
$7.36M |
$9.7M |
131.8% |
| 2024 |
$0.34 |
$7.57M |
$6.43M |
84.9% |
| 2025 |
$-0.17 |
$7.49M |
$-3.26M |
-43.5% |